참고문헌
- Benson AB, Abrams TA, Ben JE, et al (2009). NCCN clinical practice guidelings in omcology: hepatobiliary cancers. J Natl Compr Canc Netw, 7, 350-59. https://doi.org/10.6004/jnccn.2009.0027
- Bruix J, Sherman M, Llovet JM, et al (2001). Clinical management of hepatocellular carcinoma: conclusions of the Barcelona-2000 EASL conference. European Association for the study of the Liver. J Hepatol, 35, 421-30. https://doi.org/10.1016/S0168-8278(01)00130-1
- Burrel M, Reig M, Forner A, et al (2012). Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolization (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design. J Hepatol, 56, 1330-5. https://doi.org/10.1016/j.jhep.2012.01.008
- Chinn SB, Lee FT, Kennedy, et al (2001). Effect of vascular occlusion on radfiofrequency ablation of the liver: Results in a porcine model. AJR Am J Roentgenol, 176, 789-95. https://doi.org/10.2214/ajr.176.3.1760789
- Cho YK, Kim JK, Kim WT, at al (2010). Hepatic resection versus radiofrequency ablation for very early stage hepatocellular carcinoma: a Markov model analysis. Hepatology, 51, 1284-90. https://doi.org/10.1002/hep.23466
- Germani G, Pleguezuelo M, Gurusamy, et al (2010). Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocellular: a meta-analysis. J Hepatol, 52, 380-87. https://doi.org/10.1016/j.jhep.2009.12.004
- Golfieri R, Renzulli M, Mosconi C et al (2013). Hepatocellular carcinoma responding to superselective transarterial chemoembolization: an issue of nodule dimension? J Vasc Interv Radiol, 24, 509-17. https://doi.org/10.1016/j.jvir.2012.12.013
- Hsu CY, Huang YH, Chiou YY, et al (2011). Comparision of radiofrequency ablation and transterial chemoembolization for hepatocellular carcinoma within the Milan criterial: a propensity score analysis. Liver Transpl, 17, 556-66. https://doi.org/10.1002/lt.22273
- Liapi E and Geschwind JF (2011). Transcatheter arterial chemoembolization for liver cancer: is it time to distinguish conventional from drugeluting chemoembolization? Cardiovasc Intervent Radiol, 34, 37-49. https://doi.org/10.1007/s00270-010-0012-y
- Llovet JM, Bru C, Bruix J (1999). Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis, 19, 329-38. https://doi.org/10.1055/s-2007-1007122
- Riaz A, Lewandowski RJ, Kulik L, et al (2010). Radiologicpathologic correlation of hepatocellular carcinoma treated with chemoembolization. Cardiovasc Intervent Radiol, 33, 1143-52. https://doi.org/10.1007/s00270-009-9766-5
- Reig M, Rimola J, Torres F et al (2013). Postprogression survival of patients with advanced hepatocellular carcinoma: rational for second-line trial design. Hepatology, 58, 2023-31 https://doi.org/10.1002/hep.26586
- Wilson TR, Fridlyand J, Yan Y, et al (2012). Widespread potential for growth-factor-driven resistence to anticancer kinase inhibitors. Nature, 487, 505-9. https://doi.org/10.1038/nature11249
- Xu C, Lv PH, Huang XE, Wang SX, et al (2015a). Efficacy of transarterial chemoembolization combined with radiofrequency ablation in treatment of hepatocellular carcinoma. Asian Pac J Cancer Prev, 16, 6159-62. https://doi.org/10.7314/APJCP.2015.16.14.6159
- Xu C, Huang XE, Lv PH, et al (2015b). Radiofrequency ablation in treating colorectal cancer patients with liver metastases. Asian Pac J Cancer Prev, 16, 8559-61.
- Xu C, Lv PH, Huang XE, et al (2015c). Radiofrequency ablation for liver metastases after transarterial chemoembolization: a systemic analysis. Asian Pac J Cancer Prev, 16, 5101-6. https://doi.org/10.7314/APJCP.2015.16.12.5101
- Xu C, Lv PH, Huang XE, et al (2014a). Internal-external percutaneous transhepatic biliary drainage for patients with malignant obstructive jaundice. Asian Pac J Cancer Prev, 15, 9391-4. https://doi.org/10.7314/APJCP.2014.15.21.9391
- Xu C, Lv PH, Huang XE, et al (2014b). Analysis of different ways of drainage for obstructive jaundice caused by hilar cholangiocarcinoma. Asian Pac J Cancer Prev, 15, 5617-20. https://doi.org/10.7314/APJCP.2014.15.14.5617
- Xu C, Huang XE, Wang SX, et al (2014c). Drainage Alone or Combined with Anti-tumor Therapy for Treatment of Obstructive Jaundice Caused by Recurrence and Metastasis after Primary Tumor Resection. Asian Pac J Cancer Prev, 15, 2681-4. https://doi.org/10.7314/APJCP.2014.15.6.2681
- Xu C, Lv PH, Huang XE, et al (2014d). Safety and efficacy of sequential transcatheter arterial chemoembolization and portal vein embolization prior to major hepatectomy for patients with HCC. Asian Pac J Cancer Prev, 15, 703-6. https://doi.org/10.7314/APJCP.2014.15.2.703
- Yang JD, Kim WR, Park KW, et al (2012). Model to estimate survival in ambulatory patients with hepatocellular carcinoma. Hepatology, 56, 614-21. https://doi.org/10.1002/hep.25680
- Yau T, Tang VY, Yao TJ, at al (2014). Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma. Gastroenterology, 146, 1691-700. https://doi.org/10.1053/j.gastro.2014.02.032